OraSure Technologies, Inc. (NASDAQ:OSUR) went lower by -16.53% to close at $ 5.91. The company exchanged total volume of 5.45 million shares throughout course of last trade however it holds an average trading capacity of 617.06 thousand shares. Shares of company began trading at $7.06 climbed to high of $7.19 touched the low of $5.81.
The company is trading below its 50-day moving averages of 7.15 and down from 200-day moving averages of 6.74. The firm has price to book ratio of 2.41 and its price to sale ratio was 3.23.
OraSure Technologies (OSUR), a market leader in point of care diagnostics, reported recently that OraSure Technologies and AbbVie have mutually agreed to an early termination of their Master Program Services and Co-Promotion Contract under which the companies have been co-promoting OraSure’s OraQuick® HCV Rapid Antibody Test in the United States. The contract was originally planned to continue through December 31, 2019 and will now end on December 31, 2016.
Under the contract, which was signed in June 2014, OraSure granted exclusive rights to AbbVie to co-promote the OraQuick® HCV test in certain U.S. markets and provided certain additional services in support of HCV testing in exchange for up to $75 million from AbbVie in exclusivity payments over the term of the contract.
OraSure Technologies, Inc.’s (OSUR) has price-to-cash ratio of 3.21 and price to sale ratio of 2.69. The company net profit margin is 8.60% and gross profit margin is 68.70%. A look on the firm performance, its monthly performance is -25.10% and a quarterly performance of -17.69%. The stock price is moving down from its 20 days moving average with -17.96% and isolated negatively from 50 days moving average with -17.09%.
bluebird bio, Inc. (NASDAQ:BLUE) surged +2.51% and closed the trade at $ 43.29. The company recorded a trading capacity of 1.53 million shares above its three months average daily volume of 971.22 thousand shares. During the last trade, shares reached to high price of $44.00 and touched the low price of $41.11. The stock’s 50-day moving average is noted at $41.82 and its 200-day moving average is stands at $47.23.
Additionally, the company has EPS of -5.55. The company has market capitalization of $1.60B.
The average true range of bluebird bio, Inc.’s (BLUE) is recorded at 2.71 and the relative strength index of the stock stands 53.15. The stock price is going above to its 52 week low with 22.39% and lagging behind from its 52 week high with -74.72%. Analyst recommendation for this stock stands at 1.80. A look on the firm performance, its monthly performance is -4.86% and a quarterly performance of -0.39%. The stock price is trading downbeat from its 200 days moving average with -27.60% and up from 50 days moving average with 1.97%.